The global infectious disease therapeutics market is expected to post a CAGR of over 4% during the period 2019-2023, according to the latest market research report by Technavio. A key factor driving the growth of the global infectious disease therapeutics market is the growing awareness of infectious diseases. Awareness campaigns for spotting the signs and symptoms of infectious diseases and methods of prevention play an important role in preventing the spread of such ... Read more
Infectious diseases are caused by pathogenic microorganisms, such as viruses, bacteria, parasites, or fungi. Diseases such as HIV/AIDS, tuberculosis, malaria, and emerging infectious diseases continue to cause immense human suffering and hinder economic and social progress, especially in developing countries. Thus, the rising prevalence of such infectious diseases worldwide is expected to boost the growth of the infectious disease therapeutics market over the forecast period.
